Delivery Order SPE2DB22D3501-SPE2DB24FTX47
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 20S. The contract has a ceiling value of $10,156.60 and a period of performance through April 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $14.2K delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for LONSURF 20 mg-8.19 mg tablets (40-count supply) with completion targeted for January 6, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $3,590.37 to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, quantity 20) with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 60 units. This non-competitive delivery order, with a firm fixed price structure, is scheduled for completion by January 5, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in a quantity of 60 tablets. This is a competitively awarded, non-set-aside delivery order with a ceiling value of $21,442.28 under firm fixed pricing. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is expected...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,599.25 fixed-price delivery order contract is for the provision of LONSURF 20 MG-8.19 MG TABLET 60S, a specialty pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTX47Delivery Order
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of the pharmaceutical product LONSURF 20 MG-8.19 MG TABLET 60S, with a potential value of $9,158.32 and a completion date of January 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery order is issued under an indefinite delivery contract (IDC) with DLA, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/19/23 |